Advertisement
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1. Leroy BE, Northrup N. Prostate cancer in dogs: comparative and clinical aspects. Vet J 2009;180:149–162.
-
2. Leroy C, Conchou F, Layssol-Lamour C, et al. Normal canine prostate gland: repeatability, reproducibility, observer-dependent variability of ultrasonographic measurements of the prostate in healthy intact Beagles. Anat Histol Embryol 2013;42:355–361.
-
3. Russo M, Vignoli M, Catone G, et al. Prostatic perfusion in the dog using contrast-enhanced Doppler ultrasound. Reprod Domest Anim 2009;44(suppl 2):334–335.
-
4. Hume C, Seiler G, Porat-Mosenco Y, et al. Cystosonographic measurements of canine bladder tumours. Vet Comp Oncol 2010;8:122–126.
-
5. Naughton JF, Widmer WR, Constable PD, et al. Accuracy of three-dimensional and two-dimensional ultrasonography for measurement of tumor volume in dogs with transitional cell carcinoma of the urinary bladder. Am J Vet Res 2012;73:1919–1924.
-
6. Leffler AJ, Hostnik ET, Warry EE, et al. Canine urinary bladder transitional cell carcinoma tumor volume is dependent on imaging modality and measurement technique. Vet Radiol Ultrasound 2018;59:767–776.
-
7. Roy C. Tumour pathology of the bladder: the role of MRI. Diagn Interv Imaging 2012;93:297–309.
-
8. Mouli S, Casalino DD, Nikolaidis P. Imaging features of common and uncommon bladder neoplasms. Radiol Clin North Am 2012;50:301–316.
-
9. Dighe MK, Bhargava P, Wright J. Urinary bladder masses: techniques, imaging spectrum, and staging. J Comput Assist Tomogr 2011;35:411–424.
-
10. Green DA, Durand M, Gumpeni N, et al. Role of magnetic resonance imaging in bladder cancer: current status and emerging techniques. BJU Int 2012;110:1463–1470.
-
11. Aigner F, Mitterberger M, Rehder P, et al. Status of transrectal ultrasound imaging of the prostate. J Endourol 2010;24:685–691.
-
12. Lahoti AM, Dhok AP, Rantnaparkhi CR, et al. Role of magnetic resonance imaging, magnetic resonance spectroscopy and transrectal ultrasound in evaluation of prostatic pathologies with focus on prostate cancer. Pol J Radiol 2017;82:827–836.
-
13. Sedelaar JP, De La Rosette JJ, Beerlage HP, et al. Transrectal ultrasound imaging of the prostate: review and perspectives of recent developments. Prostate Cancer Prostatic Dis 1999;2:241–252.
-
14. Pallwein L, Mitterberger M, Pelzer A, et al. Ultrasound of prostate cancer: recent advances. Eur Radiol 2008;18:707–715.
-
15. Tang Y, Liu Z, Tang L, et al. Significance of MRI/transrectal ultrasound fusion three-dimensional model-guided, targeted biopsy based on transrectal ultrasound-guided systematic biopsy in prostate cancer detection: a systematic review and meta-analysis. Urol Int 2018;100:57–65.
-
16. Wegelin O, van Melick HHE, Hooft L, et al. Comparing three different techniques for magnetic resonance imaging-targeted prostate biopsies: a systematic review of in-bore versus magnetic resonance imaging-transrectal ultrasound fusion versus cognitive registration. Is there a preferred technique? Eur Urol 2017;71:517–531.
-
17. Miyashita H, Watanabe H, Ohe H, et al. Transrectal ultrasonotomography of the canine prostate. Prostate 1984;5:453–457.
-
18. Juniewicz PE, Ewing LL, Dahnert WF, et al. Determination of canine prostatic size in situ: comparison of direct caliper measurement with radiologic and transrectal ultrasonographic measurements. Prostate 1989;14:55–64.
-
19. Levy DA, Cromeens DM, Evans R, et al. Transrectal ultrasound-guided intraprostatic injection of absolute ethanol with and without carmustine: a feasibility study in the canine model. Urology 1999;53:1245–1251.
-
20. Jiang Z, Holyoak GR, Bartels KE, et al. In vivo trans-rectal ultrasound-coupled optical tomography of a transmissible venereal tumor model in the canine pelvic canal. J Biomed Opt 2009;14:030506.
-
21. Jiang Z, Piao D, Bartels KE, et al. Transrectal ultrasound-integrated spectral optical tomography of hypoxic progression of a regressing tumor in a canine prostate. Technol Cancer Res Treat 2011;10:519–531.
-
22. Jiang Z, Piao D, Holyoak GR, et al. Trans-rectal ultrasound-coupled spectral optical tomography of total hemoglobin concentration enhances assessment of the laterality and progression of a transmissible venereal tumor in canine prostate. Urology 2011;77:237–242.
-
23. Keller JM, Schade GR, Ives K, et al. A novel canine model for prostate cancer (Erratum published in Prostate 2014;74;1249). Prostate 2013;73:952–959.
-
24. Blackburn AL, Berent AC, Weisse CW, et al. Evaluation of outcome following urethral stent placement for the treatment of obstructive carcinoma of the urethra in dogs: 42 cases (2004–2008). J Am Vet Med Assoc 2013;242:59–68.
-
25. McMillan SK, Knapp DW, Ramos-Vara JA, et al. Outcome of urethral stent placement for management of urethral obstruction secondary to transitional cell carcinoma in dogs: 19 cases (2007–2010). J Am Vet Med Assoc 2012;241:1627–1632.
-
26. Weisse C, Berent A, Todd K, et al. Evaluation of palliative stenting for management of malignant urethral obstructions in dogs. J Am Vet Med Assoc 2006;229:226–234.
-
27. Bennett TC, Matz BM, Henderson RA, et al. Total prostatectomy as a treatment for prostatic carcinoma in 25 dogs. Vet Surg 2018;47:367–377.
-
28. Bacon N, Souza CH, Franz S. Total cysto-prostatectomy: technique description and results in 2 dogs. Can Vet J 2016;57:141–146.
-
29. Jiang Z, Piao D, Xu G, et al. Trans-rectal ultrasound-coupled near-infrared optical tomography of the prostate, part II: experimental demonstration. Opt Express 2008;16:17505–17520.
-
30. Sauvain JL, Palascak P, Bourscheid D, et al. Value of power Doppler and 3D vascular sonography as a method for diagnosis and staging of prostate cancer. Eur Urol 2003;44:21–30.
-
31. Sauvain JL, Palascak P, Bourscheid D, et al. Power Doppler and 3D vascular sonography of intraprostatic blood supply: assessment criteria and value for the diagnostic and clinical staging of prostatic cancer. Prog Urol 2000;10:237–245.
-
32. Sauvain JL, Sauvain E, Rohmer P, et al. Value of transrectal power Doppler sonography in the detection of low-risk prostate cancers. Diagn Interv Imaging 2013;94:60–67.
-
33. Hagen EK, Forsberg F, Liu JB, et al. Contrast-enhanced power Doppler imaging of normal and decreased blood flow in canine prostates. Ultrasound Med Biol 2001;27:909–913.
-
34. Newell SM, Neuwirth L, Ginn PE, et al. Doppler ultrasound of the prostate in normal dogs and in dogs with chronic lymphocytic-lymphoplasmocytic prostatitis. Vet Radiol Ultrasound 1998;39:332–336.
-
35. Macri F, Di Pietro S, Mangano C, et al. Quantitative evaluation of canine urinary bladder transitional cell carcinoma using contrast-enhanced ultrasonography. BMC Vet Res 2018;14:84.
-
36. Pollard RE, Watson KD, Hu X, et al. Feasibility of quantitative contrast ultrasound imaging of bladder tumors in dogs. Can Vet J 2017;58:70–72.
Advertisement
Use of transrectal ultrasonography for assessment of the size and location of prostatic carcinoma in dogs
Abstract
OBJECTIVE
To evaluate the use of transrectal ultrasonography (TRUS) for the assessment of prostatic tumors in dogs and to compare results for TRUS with results for other imaging modalities.
ANIMALS
10 client-owned male dogs.
PROCEDURES
Client-owned dogs identified with prostatic carcinoma were enrolled. Fluoroscopy, transabdominal ultrasonography (TAUS), TRUS, and MRI were performed on all dogs. Tumor measurements, urethral penetration (identification of abnormal tissue within the urethral lumen), and tumor extension into the urinary tract were recorded for all imaging modalities. Agreement between results for MRI (considered the criterion-referenced standard) and results for other modalities were compared.
RESULTS
Median body weight of the 10 dogs was 26.3 kg (range, 9.4 to 49.5 kg). No complications were encountered during or after TRUS. Significant moderate to good agreements (intraclass correlation coefficients, 0.60 to 0.86) among TAUS, TRUS, fluoroscopy, and MRI were identified for tumor length and height. Assessments of urethral penetration and tumor extension into the bladder with TRUS did not differ significantly from those made with MRI and were superior in terms of absolute agreement with MRI when compared with those for TAUS.
CONCLUSIONS AND CLINICAL RELEVANCE
TRUS was successfully and safely used to evaluate prostatic carcinoma in dogs. There was moderate to good agreement with MRI results for tumor height and length measurements, and TRUS was found to be superior to TAUS for some assessments. Transrectal ultrasonography can be considered an adjunctive imaging modality for the performance of prostatic interventional procedures or assessment of response to treatment.
Contributor Notes
Powered by PubFactory